Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The 2019 Genitourinary Pathology Society (GUPS) White Paper on Contemporary Grading of Prostate Cancer
Jonathan I. Epstein, Mahul B. Amin, Samson W. Fine, et al.
Archives of Pathology & Laboratory Medicine (2020) Vol. 145, Iss. 4, pp. 461-493
Open Access | Times Cited: 203

Showing 1-25 of 203 citing articles:

The 2022 World Health Organization Classification of Tumors of the Urinary System and Male Genital Organs—Part B: Prostate and Urinary Tract Tumors
George J. Netto, Mahul B. Amin, Daniel M. Berney, et al.
European Urology (2022) Vol. 82, Iss. 5, pp. 469-482
Closed Access | Times Cited: 176
Single cell analysis of cribriform prostate cancer reveals cell intrinsic and tumor microenvironmental pathways of aggressive disease
Hong Yuen Wong, Quanhu Sheng, Amanda B. Hesterberg, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 67
Artificial intelligence-aided optical imaging for cancer theranostics
Mengze Xu, Zhiyi Chen, Junxiao Zheng, et al.
Seminars in Cancer Biology (2023) Vol. 94, pp. 62-80
Closed Access | Times Cited: 23
Prostate zones and cancer: lost in transition?
Amin Ali, Alexander Du Feu, Pedro Oliveira, et al.
Nature Reviews Urology (2021) Vol. 19, Iss. 2, pp. 101-115
Closed Access | Times Cited: 47
French AFU Cancer Committee Guidelines - Update 2022-2024: prostate cancer - Diagnosis and management of localised disease
Guillaume Ploussard, G. Fiard, É. Barret, et al.
Progrès en Urologie (2022) Vol. 32, Iss. 15, pp. 1275-1372
Closed Access | Times Cited: 36
WHOClassification of Tumours fifth edition: evolving issues in the classification, diagnosis, and prognostication of prostate cancer
James G. Kench, Mahul B. Amin, Daniel M. Berney, et al.
Histopathology (2022) Vol. 81, Iss. 4, pp. 447-458
Open Access | Times Cited: 29
Nondestructive 3D pathology with analysis of nuclear features for prostate cancer risk assessment
Robert Serafin, Can Koyuncu, Weisi Xie, et al.
The Journal of Pathology (2023) Vol. 260, Iss. 4, pp. 390-401
Open Access | Times Cited: 19
Prostate Pathology: What is New in the 2022 WHO Classification of Urinary and Male Genital Tumors?
Jerasit Surintrspanont, Ming Zhou
Pathologica (2023), pp. 1-16
Open Access | Times Cited: 18
Impact of Epithelial Histological Types, Subtypes, and Growth Patterns on Oncological Outcomes for Patients with Nonmetastatic Prostate Cancer Treated with Curative Intent: A Systematic Review
Giancarlo Marra, Geert J.L.H. van Leenders, Fabio Zattoni, et al.
European Urology (2023) Vol. 84, Iss. 1, pp. 65-85
Open Access | Times Cited: 17
Prostate Cancer: Genetics, Epigenetics and the Need for Immunological Biomarkers
Guzel Rafikova, I. R. Gilyazova, Kadriia Enikeeva, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 16, pp. 12797-12797
Open Access | Times Cited: 16
Proposal for an optimised definition of adverse pathology (unfavourable histology) that predicts metastatic risk in prostatic adenocarcinoma independent of grade group and pathological stage
Jane Nguyen, Lara R. Harik, Eric A. Klein, et al.
Histopathology (2024)
Closed Access | Times Cited: 5
Artificial intelligence in pathologic diagnosis, prognosis and prediction of prostate cancer
Min Zhu, Rasoul Sali, F. Baba, et al.
American Journal of Clinical and Experimental Urology (2024) Vol. 12, Iss. 4, pp. 200-215
Closed Access | Times Cited: 5
Intermediate risk prostate tumors contain lethal subtypes
William L. Harryman, James P. Hinton, Raquel Sainz, et al.
Frontiers in Urology (2025) Vol. 4
Open Access
Identification of intraductal‐to‐invasive spatial transitions in prostate cancer: proposal for a new unifying model on intraductal carcinogenesis
L. Lucia Rijstenberg, Hridya Harikumar, Esther I. Verhoef, et al.
Histopathology (2025)
Open Access
Confirmatory Biopsy Outcomes in Patients with Grade Group 2 Prostate Cancer: Implications for Early Management
Riccardo Leni, Emily Vertosick, Nicole Liso, et al.
European Urology Open Science (2025) Vol. 72, pp. 46-53
Open Access
Atypical Intraductal Proliferation in Prostate Needle Core Biopsy
Roshan Bhattarai, Jesse K. McKenney, Reza Alaghehbandan, et al.
The American Journal of Surgical Pathology (2025)
Closed Access
Prospective Clinical Implementation of Paige Prostate Detect Artificial Intelligence Assistance in the Detection of Prostate Cancer in Prostate Biopsies: CONFIDENT P Trial Implementation of Artificial Intelligence Assistance in Prostate Cancer Detection
Rachel N Flach, Carmen van Dooijeweert, Tri Q. Nguyen, et al.
JCO Clinical Cancer Informatics (2025), Iss. 9
Closed Access
Prostate Cancer
Ruben Raychaudhuri, Dingbo Lin, Bruce Montgomery
JAMA (2025)
Closed Access
Factors Associated With Upgrades From Biopsy Gleason Grades 1–3 to Radical Prostatectomy Gleason Grades 4–5 in Prostate Cancer Patients
Le Yu, Kewei Chen, Min Lü, et al.
European Journal of Cancer Care (2025) Vol. 2025, Iss. 1
Open Access
The 2019 International Society of Urological Pathology (ISUP) Consensus Conference on Grading of Prostatic Carcinoma
Kenneth A. Iczkowski, Geert J.L.H. van Leenders, Theodorus H. van der Kwast
The American Journal of Surgical Pathology (2021) Vol. 45, Iss. 7, pp. 1007-1007
Open Access | Times Cited: 38
Pituitary adenoma or neuroendocrine tumour: the need for an integrated prognostic classification
Ken K. Y. Ho, Ursula B. Kaiser, P Chanson, et al.
Nature Reviews Endocrinology (2023) Vol. 19, Iss. 11, pp. 671-678
Closed Access | Times Cited: 15
Cribriform pattern and intraductal carcinoma of the prostate can have a clinicopathological impact, regardless of their percentage and/or number of cores
Yoichiro Okubo, Shinya Sato, Chie Hasegawa, et al.
Human Pathology (2023) Vol. 135, pp. 99-107
Open Access | Times Cited: 12
Bioprinted research models of urological malignancy
Guanyi Wang, Xiongmin Mao, Wang Wang, et al.
Exploration (2024) Vol. 4, Iss. 4
Closed Access | Times Cited: 4
Application of Photoactive Compounds in Cancer Theranostics: Review on Recent Trends from Photoactive Chemistry to Artificial Intelligence
Patryk Szymaszek, Małgorzata Tyszka‐Czochara, Joanna Ortyl
Molecules (2024) Vol. 29, Iss. 13, pp. 3164-3164
Open Access | Times Cited: 4
Head to head: should the intraductal component of invasive prostate cancer be graded?
Murali Varma, Jonathan I. Epstein
Histopathology (2020) Vol. 78, Iss. 2, pp. 231-239
Open Access | Times Cited: 35
Page 1 - Next Page

Scroll to top